Navigation Links
Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
Date:9/9/2008

g studied in a Phase 2 trial of acute infectious mononucleosis, a syndrome commonly seen in adolescents and young adults, caused by Epstein-Barr virus (EBV), also a member of the herpes virus family. "Further studies of valomaciclovir outside herpes zoster are warranted and we plan to examine uses of this drug in major diseases associated with EBV," commented Dr. Murphy.

Epiphany Biosciences is a privately-held company developing therapeutic products and diagnostic technologies that treat or help prevent the spread of pathogenic viruses, including varicella virus (VZV), Epstein-Barr virus (EBV) and hepatitis C virus (HCV).

Fred Volinsky, CEO

415 765 7193


'/>"/>
SOURCE Epiphany Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles
2. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
3. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
4. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
5. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
6. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
7. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
8. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
9. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
10. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
11. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... , Jan. 14, 2014 HeartWare International, Inc ... of less invasive, miniaturized circulatory support technologies that are ... that it expects revenues for the fourth quarter of ... 2013 revenues to approximately $208 million. "Our ...
(Date:1/14/2014)... Jan. 14, 2014 The Brandeis Medical Center, led by Dr. ... a premier and affordable laser tattoo removal experience with the advanced ... is in providing high quality cosmetic services with cutting edge medical ... " Southern California has seen a dramatic increase ...
(Date:1/14/2014)... Va. , Jan. 14, 2014 Animal Emergency Critical Care, ... Leesburg, Virginia is the first in ... oxygen chamber. Dr. Susan M. Barnes , ... Dr. Barnes and husband, Dr. Cole Taylor , are avid ...
Breaking Medicine Technology:HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:ATS Medical Announces Fourth Quarter and Full Year 2009 Results 2ATS Medical Announces Fourth Quarter and Full Year 2009 Results 3ATS Medical Announces Fourth Quarter and Full Year 2009 Results 4ATS Medical Announces Fourth Quarter and Full Year 2009 Results 5ATS Medical Announces Fourth Quarter and Full Year 2009 Results 6ATS Medical Announces Fourth Quarter and Full Year 2009 Results 7ATS Medical Announces Fourth Quarter and Full Year 2009 Results 8ATS Medical Announces Fourth Quarter and Full Year 2009 Results 9ATS Medical Announces Fourth Quarter and Full Year 2009 Results 10ATS Medical Announces Fourth Quarter and Full Year 2009 Results 11ATS Medical Announces Fourth Quarter and Full Year 2009 Results 12ATS Medical Announces Fourth Quarter and Full Year 2009 Results 13ATS Medical Announces Fourth Quarter and Full Year 2009 Results 14ATS Medical Announces Fourth Quarter and Full Year 2009 Results 15ATS Medical Announces Fourth Quarter and Full Year 2009 Results 16ATS Medical Announces Fourth Quarter and Full Year 2009 Results 17ATS Medical Announces Fourth Quarter and Full Year 2009 Results 18ATS Medical Announces Fourth Quarter and Full Year 2009 Results 19ATS Medical Announces Fourth Quarter and Full Year 2009 Results 20ATS Medical Announces Fourth Quarter and Full Year 2009 Results 21WorldHeart Reports 2009 Financial Results 2WorldHeart Reports 2009 Financial Results 3WorldHeart Reports 2009 Financial Results 4WorldHeart Reports 2009 Financial Results 5WorldHeart Reports 2009 Financial Results 6WorldHeart Reports 2009 Financial Results 7WorldHeart Reports 2009 Financial Results 8
(Date:4/17/2014)... NY (April 16, 2014) The cause of neuronal ... new study proposes that neurons may be mistaken for ... system, similar to the way autoimmune diseases like type ... body,s cells. The study was published April 16, 2014, ... new, and likely controversial, idea in Parkinson,s disease; but ...
(Date:4/17/2014)... NEW YORK April 17, 2014 EcoHealth Alliance, ... public health issues, published a comprehensive review today examining ... and Marburg virus. The review calls for improved global ... such as the recent outbreak of Ebola in West ... in the countries of Guinea and Liberia. According ...
(Date:4/17/2014)... scientists and their partners have found that their proprietary ... transmission of multiple sexually transmitted infections (STIs) in both ... virus 2 (HSV-2), and human papillomavirus (HPV). The USAID-funded ... is effective against multiple strains of HIV, and has ... three viruses of at least eight hours prior to ...
(Date:4/17/2014)... less than 40 years away from a food shortage ... according to a top scientist at the U.S. Agency ... history, food production will be limited on a global ... said Dr. Fred Davies, senior science advisor for the ... as politically destabilizing by 2050 as energy issues are ...
(Date:4/17/2014)... whose work has transformed cancer care in Northern Ireland, ... Academy of Cancer Sciences., The Academy, which was launched ... distinguished oncologists and cancer researchers which aims to reduce ... , Professor Johnston, whose leadership has seen cancer survival ... the UK league table to near the top, has ...
Breaking Medicine News(10 mins):Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2Health News:Food shortages could be most critical world issue by mid-century 2
... Society for Radiation Oncology (ASTRO), the Association of Residents ... the 2011 Educator of the Year Award. , ARRO ... recognize outstanding teachers and mentors of radiation oncology residents. ... opportunity to select one faculty member from their program ...
... UCLA,s Jonsson Comprehensive Cancer Center have developed and ... and characterizes chemical compounds that can target the ... brain tumors. Glioblastoma is one of the ... 18 months. These brain cancers consist of two ...
... , MONDAY, Oct. 10 (HealthDay News) -- In the latest ... food, Swedish scientists report that eating chocolate seems to lower ... that women who had the highest consumption of chocolate -- ... percent reduced risk of stroke. "Cocoa contains flavonoids, which ...
... mother,s womb between the father,s biological goal to produce the ... through delivery might help explain preeclampsia, an often deadly disease ... yet small enough to pass through the birth canal. In ... these conflicting goals in balance. , The findings are ...
... Legs Syndrome, you may have a higher risk of developing ... Hypertension: Journal of the American Heart Association . RLS ... intense, unpleasant leg sensations, and an irresistible urge to move ... daytime drowsiness. It affects as many as 15 percent of ...
... it is a small study and more clinical trials ... result in a reduction in brain amyloid levels in ... Online First by Archives of Neurology , one ... suggests that the accumulation of amyloid-β (Aβ) peptides in ...
Cached Medicine News:Health News:ARRO honors 39 with Educator of the Year Award 2Health News:UCLA researchers develop new way to screen for brain cancer stem cell killers 2Health News:UCLA researchers develop new way to screen for brain cancer stem cell killers 3Health News:Chocolate Could Be Sweet Defense Against Stroke 2Health News:Chocolate Could Be Sweet Defense Against Stroke 3Health News:Battle between the placenta and uterus could help explain preeclampsia 2Health News:Restless legs syndrome may raise high blood pressure risk in middle-aged women 2Health News:Small study shows association between medication and reduction in brain amyloid levels related to AD 2
Straight shafts with polished finish. Teeth: 0.12 mm. Tying platform: 5.0 mm. Wide Serrated....
Straight shafts with 0.12 mm teeth and tying platform. Serrated handle with polished finish....
Angled 45 degree shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Heavy curved shafts with 2 x 2 teeth and crisscross serrated 6 mm tying platform. Serrated handle with polished finish....
Medicine Products: